Telomerase inhibitor imetelstat in essential thrombocythemia and myelofibrosis

Daniel El Fassi, Mads E. Bjørn, Claus H. Nielsen, Hans C. Hasselbalch, Gabriela M. Baerlocher, Bart Burington, David S. Snyder, Ayalew Tefferi

Research output: Contribution to journalLetter

5 Scopus citations
Original languageEnglish (US)
Pages (from-to)2579-2581
Number of pages3
JournalNew England Journal of Medicine
Volume373
Issue number26
DOIs
StatePublished - Dec 24 2015

ASJC Scopus subject areas

  • Medicine(all)

Cite this

El Fassi, D., Bjørn, M. E., Nielsen, C. H., Hasselbalch, H. C., Baerlocher, G. M., Burington, B., Snyder, D. S., & Tefferi, A. (2015). Telomerase inhibitor imetelstat in essential thrombocythemia and myelofibrosis. New England Journal of Medicine, 373(26), 2579-2581. https://doi.org/10.1056/NEJMc1512663